Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Noncirrhotic portal hypertension: another cause of liver disease in HIV patients.

Mendizabal M, Craviotto S, Chen T, Silva MO, Reddy KR.

Ann Hepatol. 2009 Oct-Dec;8(4):390-5.

PMID:
20009143
2.

Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection.

Saifee S, Joelson D, Braude J, Shrestha R, Johnson M, Sellers M, Galambos MR, Rubin RA.

Clin Gastroenterol Hepatol. 2008 Oct;6(10):1167-9. doi: 10.1016/j.cgh.2008.04.023. Epub 2008 Jul 17.

PMID:
18639498
3.

A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection.

Yajima K, Uehira T, Otera H, Koizumi Y, Watanabe D, Kodama Y, Kuzushita N, Nishida Y, Mita E, Mano M, Shirasaka T.

J Infect Chemother. 2014 Sep;20(9):582-5. doi: 10.1016/j.jiac.2014.06.005. Epub 2014 Jul 15.

PMID:
25034388
4.

Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.

Kovari H, Ledergerber B, Peter U, Flepp M, Jost J, Schmid P, Calmy A, Mueller NJ, Muellhaupt B, Weber R; Swiss HIV Cohort Study.

Clin Infect Dis. 2009 Aug 15;49(4):626-35. doi: 10.1086/603559.

5.

Noncirrhotic portal hypertension in HIV infection.

Vispo E, Morello J, Rodriguez-Novoa S, Soriano V.

Curr Opin Infect Dis. 2011 Feb;24(1):12-8. doi: 10.1097/QCO.0b013e3283420f08. Review.

PMID:
21157331
6.

Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV.

Schiano TD, Kotler DP, Ferran E, Fiel MI.

Am J Gastroenterol. 2007 Nov;102(11):2536-40. Epub 2007 Jul 19.

PMID:
17640321
7.

Noncirrhotic portal hypertension in HIV-infected patients: a case control evaluation and review of the literature.

Cesari M, Schiavini M, Marchetti G, Caramma I, Ortu M, Franzetti F, Galli M, Antinori S, Milazzo L.

AIDS Patient Care STDS. 2010 Nov;24(11):697-703. doi: 10.1089/apc.2010.0160. Epub 2010 Oct 23. Review.

PMID:
20969464
8.

Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings.

Vispo E, Moreno A, Maida I, Barreiro P, Cuevas A, Albertos S, Soriano V.

AIDS. 2010 May 15;24(8):1171-6. doi: 10.1097/QAD.0b013e3283389e26.

PMID:
20299955
9.

Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome.

Maida I, Garcia-Gasco P, Sotgiu G, Rios MJ, Vispo ME, Martin-Carbonero L, Barreiro P, Mura MS, Babudieri S, Albertos S, Garcia-Samaniego J, Soriano V.

Antivir Ther. 2008;13(1):103-7.

PMID:
18389904
10.

Non-cirrhotic portal hypertension in HIV-infected individuals.

Scourfield A, Waters L, Holmes P, Panos G, Randell P, Jackson A, Mandalia S, Gazzard B, Nelson M.

Int J STD AIDS. 2011 Jun;22(6):324-8. doi: 10.1258/ijsa.2010.010396.

PMID:
21680667
11.

The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV.

Schiano TD, Uriel A, Dieterich DT, Fiel MI.

Virchows Arch. 2011 Feb;458(2):231-5. doi: 10.1007/s00428-010-1004-7. Epub 2010 Nov 6.

PMID:
21057809
12.

[Non-cirrhotic portal hypertension: rare cause of upper gastrointestinal bleeding].

Schouten JN, Verheij J, Janssen HL.

Ned Tijdschr Geneeskd. 2010;154:A1276. Dutch.

PMID:
20456763
13.

Response to Mallet et al., 'Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients'.

Garvey LJ, Thomson EC, Lloyd J, Cooke GS, Goldin RD, Main J.

AIDS. 2007 Jul 11;21(11):1494-5. No abstract available.

PMID:
17589202
14.
15.
16.

The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study.

Cotte L, Bénet T, Billioud C, Miailhes P, Scoazec JY, Ferry T, Brochier C, Boibieux A, Vanhems P, Chevallier M, Zoulim F.

J Hepatol. 2011 Mar;54(3):489-96. doi: 10.1016/j.jhep.2010.07.030. Epub 2010 Sep 19.

PMID:
21056493
17.

Severe liver disease associated with prolonged exposure to antiretroviral drugs.

Maida I, Núñez M, Ríos MJ, Martín-Carbonero L, Sotgiu G, Toro C, Rivas P, Barreiro P, Mura MS, Babudieri S, Garcia-Samaniego J, González-Lahoz J, Soriano V.

J Acquir Immune Defic Syndr. 2006 Jun;42(2):177-82.

PMID:
16688096
18.

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.

Reiberger T, Ferlitsch A, Sieghart W, Kreil A, Breitenecker F, Rieger A, Schmied B, Gangl A, Peck-Radosavljevic M.

J Viral Hepat. 2010 Jun;17(6):400-9. doi: 10.1111/j.1365-2893.2009.01197.x. Epub 2009 Sep 15.

PMID:
19780945
19.

Noncirrhotic portal hypertension associated with didanosine: a case report and literature review.

Chang HM, Tsai HC, Lee SS, Wann SR, Chen YS.

Jpn J Infect Dis. 2012;65(1):61-5. Review.

20.

Clinical factors that predict noncirrhotic portal hypertension in HIV-infected patients: a proposed diagnostic algorithm.

Parikh ND, Martel-Laferriere V, Kushner T, Childs K, Vachon ML, Dronamraju D, Taylor C, Fiel MI, Schiano T, Nelson M, Agarwal K, Dieterich DT.

J Infect Dis. 2014 Mar 1;209(5):734-8. doi: 10.1093/infdis/jit412. Epub 2013 Aug 2.

PMID:
23911709

Supplemental Content

Support Center